The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
RRIA 2012 (Rapid Response Innovation Awards), 2012Novel Protease Pathway in Parkinson’s Disease
Objective/Rationale:
Mitochondria are essential for generating energy for all the cells in the human body. Many human diseases are caused by malfunctions in mitochondria, including Parkinson’s... -
Rapid Response Innovation Awards, 2012Enzymatic Degradation of Brain Complex Gangliosides to Increase Endogenous GM1 Levels: Potential Neuroprotective/Neurorestorative Therapy for Parkinson’s disease
Objective/Rationale:
Pre-clinical studies and clinical studies with GM1 ganglioside in Parkinson’s disease patients suggest potential symptomatic and disease modifying effects of GM1 on Parkinson’s... -
LRRK2 Cohort Consortium, 2012Parkinson’s Institute LRRK2 Cohort: Clinical Phenotype, Pre/Non-Motor and Environmental Risk Assessment
Objective/Rationale:
The objective of this award is to better understand the clinical symptoms of patients that carry the most common genetic risk factor for PD the LRRK2 G2019S variant and what role... -
Rapid Response Innovation Awards, 2012Nigrostriatal Alpha-Synuclein Over-Expression in Young and Aged Pre-Clinical Models
Objective/Rationale:
Accurate pre-clinical models of Parkinson’s disease are needed in order to test novel therapies as well as to further our understanding of the disease itself. The molecule alpha... -
MJFF Research Grant, 2012Generation of Phospho-Ser65 Parkin and Phospho-Thr257 PINK1 Pre-clinical Monoclonal Antibodies and Characterization of Total PINK1 Pre-clinical Monoclonal Antibodies
Objective/Rationale:
Mutations in an enzyme known as PINK1 can cause Parkinson’s disease. There has been
great interest in understanding the function of PINK1 since uncovering the pathways that
PINK1 is... -
MJFF Research Grant, 2012Design of HdAd Type 5 LRRK2 Expression Vectors
Objective/Rationale:
LRRK2 is a gene that is has been implicated in Parkinson’s disease. LRRK2 is a large cDNA of approximately 7.6 kb that precludes it from being expressed in viral vectors such as...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.